Functional relevance of SATB1 in immune regulation and tumorigenesis

Publication Type:
Journal Article
Citation:
Biomedicine and Pharmacotherapy, 2018, 104 pp. 87 - 93
Issue Date:
2018-08-01
Metrics:
Full metadata record
Files in This Item:
Filename Description Size
OCC-127013_AM.pdfAccepted Manuscript Version241.58 kB
Adobe PDF
© 2018 The Special AT-rich Sequence Binding Protein 1 (SATB1) is a chromatin organiser and transcription factor which regulates numerous cellular processes such as differentiation, proliferation and apoptosis through effects on gene expression. SATB1 undergoes various post-translational modifications, which determine its interaction with co-activators and co-repressors to induce regulation of gene transcription. SATB1 is an identified oncogene, its increased expression is associated with poor prognosis in many cancers. This paper provides a review on SATB1-mediated immune responses and on its target genes in the context of tumorigenesis and tumour progression. Specifically, we discuss the role of SATB1 in tumour immunity, Epithelial to Mesenchymal Transition (EMT), metastasis and multidrug resistance. Therapeutic targeting of aberrant SATB1 may be an important strategy in the treatment of cancer.
Please use this identifier to cite or link to this item: